20 ans après: a second mutation in MAOA identified by targeted high-throughput sequencing in a family with altered behavior and cognition

[1]  C. Lord,et al.  Autism Diagnostic Observation Schedule , 2016 .

[2]  Ayumi Matsumoto,et al.  MAOA/B deletion syndrome in male siblings with severe developmental delay and sudden loss of muscle tonus , 2014, Brain and Development.

[3]  D. Murphy,et al.  Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humans , 2012, The Pharmacogenomics Journal.

[4]  Claire Redin,et al.  XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. , 2013, American journal of human genetics.

[5]  Ryan D. Darling,et al.  Monoamine oxidase A and A/B knockout mice display autistic-like features. , 2013, The international journal of neuropsychopharmacology.

[6]  Véronique Geoffroy,et al.  Targeted high-throughput sequencing for diagnosis of genetically heterogeneous diseases: efficient mutation detection in Bardet-Biedl and Alström Syndromes , 2012, Journal of Medical Genetics.

[7]  Olivier Poch,et al.  KD4v: comprehensible knowledge discovery system for missense variant , 2012, Nucleic Acids Res..

[8]  J. Graham,et al.  De novo microdeletion of Xp11.3 exclusively encompassing the monoamine oxidase A and B genes in a male infant with episodic hypotonia: a genomics approach to personalized medicine. , 2012, European journal of medical genetics.

[9]  R. Stevenson,et al.  Fragile X and X-linked intellectual disability: four decades of discovery. , 2012, American journal of human genetics.

[10]  J L Rapoport,et al.  Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia , 2011, Molecular Psychiatry.

[11]  D. Fergusson,et al.  MAOA, abuse exposure and antisocial behaviour: 30-year longitudinal study , 2011, British Journal of Psychiatry.

[12]  F. Lung,et al.  Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder , 2011, BMC Medical Genetics.

[13]  H. Ropers.  Genetics of early onset cognitive impairment. , 2010, Annual review of genomics and human genetics.

[14]  Jana Marie Schwarz,et al.  MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.

[15]  L. Gaunt,et al.  Deletion of MAOA and MAOB in a male patient causes severe developmental delay, intermittent hypotonia and stereotypical hand movements , 2010, European Journal of Human Genetics.

[16]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[17]  R. Blakely,et al.  Monoamine oxidase a promoter gene associated with problem behavior in adults with intellectual/developmental disabilities. , 2009, American journal on intellectual and developmental disabilities.

[18]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[19]  Andrew Menzies,et al.  A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation , 2009, Nature Genetics.

[20]  E. Pussard,et al.  Reference intervals for urinary catecholamines and metabolites from birth to adulthood. , 2009, Clinical biochemistry.

[21]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[22]  J. Haavik,et al.  Mutations in human monoamine‐related neurotransmitter pathway genes , 2008, Human mutation.

[23]  J. Shih,et al.  Novel monoamine oxidase A knock out mice with human-like spontaneous mutation , 2008, Neuroreport.

[24]  E. Yamashita,et al.  Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors , 2008, Proceedings of the National Academy of Sciences.

[25]  A. Caspi,et al.  MAOA, maltreatment, and gene–environment interaction predicting children's mental health: new evidence and a meta-analysis , 2006, Molecular Psychiatry.

[26]  A. Hardan,et al.  Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders. , 2005, Journal of child and adolescent psychopharmacology.

[27]  I L Cohen,et al.  Association of autism severity with a monoamine oxidase A functional polymorphism , 2003, Clinical genetics.

[28]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[29]  Christopher B. Burge,et al.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.

[30]  A. Caspi,et al.  Role of Genotype in the Cycle of Violence in Maltreated Children , 2002, Science.

[31]  S. Salzberg,et al.  GeneSplicer: a new computational method for splice site prediction. , 2001, Nucleic acids research.

[32]  D. Murphy,et al.  Screen for MAOA mutations in target human groups. , 1999, American journal of medical genetics.

[33]  D. Hamer,et al.  A functional polymorphism in the monoamine oxidase A gene promoter , 1998, Human Genetics.

[34]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.

[35]  P. Gaspar,et al.  Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. , 1995, Science.

[36]  J. Finberg,et al.  Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats. , 1994, The Journal of pharmacology and experimental therapeutics.

[37]  E. D. de Vries,et al.  Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors. , 1994, Clinical chemistry.

[38]  P. Celada,et al.  Plasma 5‐Hydroxyindoleacetic Acid as an Indicator of Monoamine Oxidase‐A Inhibition in Rat Brain and Peripheral Tissues , 1993, Journal of neurochemistry.

[39]  M. Nelen,et al.  Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. , 1993, Science.

[40]  M. Nelen,et al.  X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. , 1993, American journal of human genetics.

[41]  J. Shih,et al.  Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines. , 1993, Molecular pharmacology.

[42]  D. Murphy,et al.  Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. , 1992, American journal of medical genetics.

[43]  H. Zoghbi,et al.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.

[44]  M. Bös,et al.  Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A. , 1990, Molecular pharmacology.

[45]  S. Sparrow,et al.  Diagnostic uses of the Vineland Adaptive Behavior Scales. , 1985, Journal of pediatric psychology.

[46]  R. Denney,et al.  Human liver MAO-A and MAO-B separated by immunoaffinity chromatography with MAO-B-specific monoclonal antibody. , 1982, Science.